Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial  

作　　者：David Erlinge 

机构地区：[1]不详

出　　处：《四川生理科学杂志》2024年第11期2460-2460,共1页

摘　　要：Background:Persistent non-plateauing adverse event rates in patients who underwent percutaneous coronary intervention(PCI)remain a challenge.A bioadaptor is a novel implant that addresses this issue by restoring the haemodynamic modulation of the artery,allowing cyclic pulsatility,vasomotion,and adaptative remodelling,by unlocking and providing dynamic support to the artery.We aimed to assess outcomes with the device versus a contemporary drug-eluting stent(DES)in a representative PCI population.

关 键 词：IMPLANT coronary CONTEMPORARY 

分 类 号：R54[医药卫生—心血管疾病]